SUMMARY A 2-year-old girl with 5,10-methylenetetrahydrofolate reductase deficiency developed subacute combined degeneration of the cord and a leuco-encephalopathy which was confirmed at necropsy. Total folate concentrations in serum, red cells and CSF were markedly reduced whereas vitamin B12 concentrations were normal. In addition the patient had Parkinsonism and reduced concentrations of homovanillic acid, 5-hydroxyindoleacetic acid and total biopterins in cerebrospinal fluid. Folic acid administration was accompanied by fits and acute deterioration in the movement disorder. At necropsy the basal ganglia showed no detectable abnormality. Case report L. C. was born at term weighing 3030 g. She developed normally during the first year of life but thereafter progress slowed. She did not walk until 18 months of age and at 2 /4 years she had only 6 or 7 words and no sentences. At this age she had a febrile illness with drowsiness and over the course of three weeks developmental regression occurred. She became ataxic, stopped walking, crawling, smiling and feeding herself and became incontinent. On examination her weight and length were on the 75th centiles whereas head circumference was on the 3rd centile. Head circumference at the age of 4 months had been on the 50th centile suggesting that impaired brain growth had developed after this age. She was withdrawn, immobile and apathetic, becoming more severely hypokinetic as her disease progressed. Her expression was mostly blank but she appeared frightened when disturbed. There were fine, semi-purposeful movements in the limbs and a Parkinsonian tremor in the arms with cogwheel rigidity and pill-rolling. The movement disorder and the level of social responsiveness fluctuated by the hour. When she could be persuaded to reach out for objects there was also a marked intention tremor. Fasciculation was visible in the muscles of the thigh and tongue and gross wasting was present in the small and large muscles of all limbs. Tone was increased in the legs which were held flexed at the knee and extended at the ankle. Tendon jerks were brisk and plantar responses were extensor; in the terminal stages of the illness ankle jerks were lost. There was a normal response to painful stimuli but it was not possible to assess sensory function more precisely. The optic discs and retinae were normal in all respects and so far as it could be tested vision was 920 group.bmj.com on October 9, 2016 -Published by
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the EEG, and an acute Parkinsonian crisis including Brain stem auditory evoked potential (BAEP) studies whole body tremor, drooling and rigidity. Treatment At 2 years 11 months there was a markedly prolonged was withdrawn and the additional symptoms disap-I/V interval of 5-62 ms compared with an upper limit peared over the course of a week. Three days after of normal of 4 21 ms suggesting impaired function of withdrawal of folic acid CSF amine metabolite conauditory pathways through brain stem structures. A centrations were lower than at diagnosis (table). follow-up study 3 weeks later showed further-increase.
-5CH3THF. (20 mg/day) was then introduced alone.
of the I/V interval to 5-88 ms.
There was no exacerbation of symptoms and initially Clayton, Smith, Harding, Hyland, Leonard, Leeming 922 Subacute combined degeneration due to an error offolate metabolism there appeared to be some improvement. After three weeks treatment was withdrawn during an attack of chickenpox. Re-examination of CSF HVA and 5HIAA concentrations two weeks after recovery showed that they were even lower than before and they rose again on reintroduction of 5CH3THF. Six months therapy with up to 120 mg 5CH3THF/day (given with ascorbic acid to prevent oxidative destruction) failed however to arrest neurological deterioration or to prevent amine metabolites falling to very low values. Terminally the patient developed recurrent fits and hypoventilation and she died just before her 3rd birthday.
Neuropathology
At necropsy there were no significant abnormalities except in the CNS. The brain was very small (unfixed Histologically the most prominent pathological changes occurred throughout the white matter. In the subcortical and central cerebral white matter, the corpus callosum, capsules, fornix, optic nerves and tracts there were numerous, small usually perivascular foci of demyelination (fig 2) . Myelin staining stopped abruptly at the edge of these zones within which there were numerous macrophages, hypertrophic fibre forming astrocytes and well preserved axons (fig 3a and  b) . These perivascular lesions coalesced into a larger area of demyelination in the centrum semi-ovale ( fig  4) . Some blood vessels in areas of normal myelin were : 'i. The patient described here is of particular interest since she died of subacute combined degeneration of the cord and a diffuse leuco-encephalopathy. During life the clinical features, CT scan appearance and deteriorating EEG and evoked potential studies (particularly the increasing 1/v interval of the BAEP) were compatible with progressive demyelination. At necropsy the neuropathological lesions were indistinguishable from those found in patients dying of vitamin B12 deficiency. Although less frequent than cord lesions, extensive brain changes have been described in vitamin B12 deficiency,16 17 and take the form of small perivascular foci of demyelination similar to the lesions in our patient. Detailed neuropathological description of B12 deficiency in children is lacking, but focal perivascular demyelination has been described in the cerebral white matter of a child with an inborn error of B12 metabQlisn."8
The severity of the myelin loss, particularly in thoracic cord, contrasted strikingly with minimal changes in neuronal cell bodies and axons, and with the normal myelination of nerve roots and peripheral nerve. The clinical and electrophysiological signs of muscle denervation and the reduced maximum motor conduction velocity, combined with the normal histology of peripheral nerve and anterior horn cells, we conclude were due to demyelination within the spinal cord of the axonal outflow from anterior horn cells.
In the previous post-mortem study of a patient with 5,1OCH2THF reductase deficiency spinal cord findings were not reported.19 However, the cerebral lesions, although not identified as those of subacute combined degeneration did consist of patchy perivascular and confluent demyelination with moderate astrocyte hypertrophy as in the present case. Intimal damage with secondary thrombotic changes, such as occurs in association with homocystinuria due to cystathionine sythetase deficiency, was also reported to be present.'9 The lack of vascular lesions in the present case emphasises that thrombotic damage is not an essential part of the pathogenesis of the neurological disease.
The findings reported here are consistent with the view that subacute combined degeneration is the result of defective turnover of 5CH3THF.2 36 79 10 Such a defect, whether due to deficiency of methyl B1 220 or to defective folate metabolism,14 19 might be expected to reduce turnover of methionine, sadenosylmethionine (SAM) and their derivatives8 -1O as well as folates (fig 1) . SAM is required in numerous transmethylation reactions. It is also the precursor of decarboxylated SAM, which is required in polyamine synthesis,2 1and of 5,methylthioadenosine which recent work suggests may have an important role as a source of 1 carbon groups in conversion of tetrahydrofolate (THF) to 10-formyltetrahydrofolate (IOCHOTHF).22 The latter is probably the substrate required for synthesis of folate polyglutamates, the form in which most folate cofactors are active in intermediary metabolism.
The idea that defective turnover of methionine plays an important part in the pathogenesis of subacute combined degeneration is supported by animal studies showing that methionine administration prevents neurological lesions induced by nitrous oxide.9 In addition clinical studies of patients with 5-1OCH2THF reductase deficiency, have shown that neurological deterioration can be halted or even reversed, either by a combination of folinic acid, methionine and B12,2324 or by administration of large doses (20 g/day) of betaine.25 Betaine is able to methylate homocysteine to form methionine in the liver in the absence of 5,1OCH2THF reductase.1 5 Although betaine itself may not enter the CNS, methionine and SAM26 do move across the bloodbrain barrier, thus providing a mechanism whereby turnover of these compounds could be increased within the CNS as well as in the periphery by betaine therapy.
Patients with 5,10-CH2THF reductase deficiency, despite low serum and red cell folate concentrations, do not develop haematological complications or other signs of peripheral folate deficiency.'' 4 SIn our patient peripheral nerves were normal even though CNS disease was so severe. Such disparity between peripheral and CNS disease is a well recognised feature of B12 deficiency. It seems likely that limited but adequate turnover of 5CH3THF, and/or other methyl group donors, is maintained in peripheral tissues, perhaps via dietary sources of 5CH3THF, choline, B12 and methionine, and by betaine-dependant hepatic turnover of methionine and SAM. The slow onset of neurological symptoms in our patient and others4 5 27 suggests that limited turnover of 5CH3THF is, at least for a time, also maintained in the CNS. Ultimately myelinated structures in brain and spinal cord prove more vulnerable to deficiency of 5CH3THF than peripheral tissues, perhaps because of a greater dependance on plasma 5CH3THF concentrations (for passage of folate and methyl groups across the blood-brain barrier),'5 and/or a greater requirement for methionine and its derivatives.
Acute neurological deterioration followed folic acid therapy in our patient. In a patient with dihydropteridine reductase deficiency folate lack was accompanied by increasing movement disorder and amine deficiency despite therapy with levodopa and 5-hydroxytryptophan and, as in the patient described here, folic acid administration Clayton, Smith, Harding, Hyland, Leonard, Leeming exacerbated neurological symptoms and reduced CSF concentrations of amine metabolites. The findings led us to suggest that deficiency of folate blocked the synaptic release of amines rather than their synthesis. 30 The entirely normal appearance of the basal ganglia at necropsy reported here is consistent with this suggestion.
We conclude that defective methyl folate metabolism is the key to neurological damage in subacute combined degeneration, that the harmful effects of folic acid are evidence for, rather than against, this view and that defective amine turnover is a facet of the neurological disturbance. Treatment of patients with 5-1OCH2THF reductase deficiency should be directed towards maintaining methionine turnover'3 23 25 as well as the supply of folate to the CNS. The pathogenesis of demyelination in subacute combined degeneration remains to be elucidated. Further characterisation of the neurochemistry and neuropathology of both inherited and acquired defects of folate metabolism should add to our understanding of this process.
